One pill a day? study tests easier Anti-Rejection drug routine
NCT ID NCT04773392
Summary
This study tested whether a simpler, once-daily combination of anti-rejection drugs works as well as the standard twice-daily regimen for people who have received a kidney transplant. Researchers wanted to see if the once-daily schedule could reduce side effects and make it easier for patients to take their medications correctly. The trial was small and has been terminated, so its final results are not available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Southern California
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.